We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14B
AUM Growth
-$1.09B
Cap. Flow
+$34.5M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.95%
Holding
1,364
New
25
Increased
674
Reduced
255
Closed
34

Sector Composition

Rank Sector Weight
1 Real Estate 53.25%
2 Technology 12.67%
3 Healthcare 4.74%
4 Consumer Discretionary 4.53%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTA icon
1226
Enanta Pharmaceuticals
ENTA
$367M
$1K ﹤0.01%
69
EOLS icon
1227
Evolus
EOLS
$410M
$1K ﹤0.01%
162
ERAS icon
1228
Erasca
ERAS
$6.3B
$1K ﹤0.01%
354
EWTX icon
1229
Edgewise Therapeutics
EWTX
$4.34B
$1K ﹤0.01%
254
FATE icon
1230
Fate Therapeutics
FATE
$270M
$1K ﹤0.01%
360
FHTX icon
1231
Foghorn Therapeutics
FHTX
$301M
$1K ﹤0.01%
168
FULC icon
1232
Fulcrum Therapeutics
FULC
$248M
$1K ﹤0.01%
138
GBIO
1233
DELISTED
Generation Bio
GBIO
$1K ﹤0.01%
19
GLUE icon
1234
Monte Rosa Therapeutics
GLUE
$1.86B
$1K ﹤0.01%
136
HUMA icon
1235
Humacyte
HUMA
$170M
$1K ﹤0.01%
301
IGMS
1236
DELISTED
IGM Biosciences
IGMS
$1K ﹤0.01%
88
IMRX icon
1237
Immuneering
IMRX
$274M
$1K ﹤0.01%
76
ITOS
1238
DELISTED
iTeos Therapeutics
ITOS
$1K ﹤0.01%
121
LYEL icon
1239
Lyell Immunopharma
LYEL
$318M
$1K ﹤0.01%
46
MCRB icon
1240
Seres Therapeutics
MCRB
$46.5M
$1K ﹤0.01%
25
MGNX icon
1241
MacroGenics
MGNX
$245M
$1K ﹤0.01%
209
MGTX icon
1242
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
130
MRSN
1243
DELISTED
Mersana Therapeutics
MRSN
$1K ﹤0.01%
16
MXCT icon
1244
MaxCyte
MXCT
$112M
$1K ﹤0.01%
293
NAUT icon
1245
Nautilus Biotechnolgy
NAUT
$152M
$1K ﹤0.01%
362
NRIX icon
1246
Nurix Therapeutics
NRIX
$2.51B
$1K ﹤0.01%
152
OCUL icon
1247
Ocular Therapeutix
OCUL
$1.85B
$1K ﹤0.01%
262
OMER icon
1248
Omeros
OMER
$816M
$1K ﹤0.01%
214
PGEN icon
1249
Precigen
PGEN
$1.97B
$1K ﹤0.01%
708
PMVP icon
1250
PMV Pharmaceuticals
PMVP
$58.7M
$1K ﹤0.01%
132

Similar funds

Daiwa Securities Group's Q3 2023 Portfolio in Review

As of Q3 2023, Daiwa Securities Group held 1,364 positions worth $14B, down 7.2% from $15.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.3%. Daiwa Securities Group opened 25 new positions and exited 34, leaving the 1,364-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 53% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2023 buy was Kenvue: 139,472 shares worth $2.8M.
  • Daiwa Securities Group added most to American Tower in Q3 2023, an estimated $233M increase.
  • Daiwa Securities Group's biggest Q3 2023 reduction was Digital Realty Trust, cutting an estimated $154M.
  • Daiwa Securities Group fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $5.38M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $14B portfolio in Q3 2023.
  • Daiwa Securities Group opened 25 new positions and closed 34 in Q3 2023.
  • Daiwa Securities Group's portfolio value fell 7.2% quarter-over-quarter to $14B.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.